Editorial: Endocrine complications of COVID-19: short and long.
作者信息
Asadipooya Kamyar
机构信息
Division of Endocrinology, Diabetes, and Metabolism, Barnstable Brown Diabetes and Obesity Center, University of Kentucky, Lexington, KY, United States.
出版信息
Front Endocrinol (Lausanne). 2025 Aug 4;16:1668201. doi: 10.3389/fendo.2025.1668201. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Endocrine complications of COVID-19: short and long.社论：新型冠状病毒肺炎的内分泌并发症：短期和长期影响
Front Endocrinol (Lausanne). 2025 Aug 4;16:1668201. doi: 10.3389/fendo.2025.1668201. eCollection 2025.
2
Abnormalities of Endocrine Function Tests in COVID-19-Recovered Individuals.新冠康复者内分泌功能测试异常
Indian J Endocrinol Metab. 2025 May-Jun;29(3):325-331. doi: 10.4103/ijem.ijem_32_25. Epub 2025 Jun 28.
3
ACE-2-like enzymatic activity in COVID-19 convalescents with persistent pulmonary symptoms associated with immunoglobulin.新型冠状病毒肺炎康复者中与免疫球蛋白相关的持续性肺部症状患者存在类似血管紧张素转换酶2的酶活性。
mBio. 2025 Jul 22:e0173525. doi: 10.1128/mbio.01735-25.
4
Oral Administration of Water-Soluble Curcumin Complex Prevents ARDS With the Potential for COVID-19 Treatment.口服水溶性姜黄素复合物可预防急性呼吸窘迫综合征，具有用于治疗新冠肺炎的潜力。
Phytother Res. 2025 Sep;39(9):3924-3934. doi: 10.1002/ptr.70046. Epub 2025 Jul 16.
5
Exposure to a mixture of per-and polyfluoroalkyl substances modulates pulmonary expression of ACE2 and circulating hormones and cytokines.接触全氟和多氟烷基物质混合物会调节肺 ACE2 的表达以及循环激素和细胞因子。
Toxicol Appl Pharmacol. 2022 Dec 1;456:116284. doi: 10.1016/j.taap.2022.116284. Epub 2022 Oct 18.
6
Molecular dissection of the role of ACE2 in glucose homeostasis.血管紧张素转换酶2（ACE2）在葡萄糖稳态中作用的分子剖析
Physiol Rev. 2025 Jul 1;105(3):935-973. doi: 10.1152/physrev.00027.2024. Epub 2025 Feb 7.
7
IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function.严重 COVID-19 中的 IgM 抗 ACE2 自身抗体激活补体并扰乱血管内皮功能。
JCI Insight. 2022 May 9;7(9):e158362. doi: 10.1172/jci.insight.158362.
8
Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进入受体血管紧张素转换酶2（ACE2）在人脑中的表达及其与阿尔茨海默病和2019冠状病毒病（COVID-19）的关联
Mol Psychiatry. 2025 Apr 6. doi: 10.1038/s41380-025-03006-z.
9
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的细胞进入因子血管紧张素转换酶2（ACE2）和跨膜丝氨酸蛋白酶2（TMPRSS2）在胰腺中表达，但在胰岛内分泌细胞中并不富集。
bioRxiv. 2020 Oct 20:2020.08.31.275719. doi: 10.1101/2020.08.31.275719.
10
Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19.在患有心脏疾病的患者中会发生交感神经重构和血管紧张素转换酶 2 定位改变，但严重 COVID-19 不会使其恶化。
Auton Neurosci. 2024 Feb;251:103134. doi: 10.1016/j.autneu.2023.103134. Epub 2023 Dec 1.
本文引用的文献
1
Thyroid disorders and COVID-19: a comprehensive review of literature.甲状腺疾病与2019冠状病毒病：文献综述
Front Endocrinol (Lausanne). 2025 May 19;16:1535169. doi: 10.3389/fendo.2025.1535169. eCollection 2025.
2
ACE2, a therapeutic target of COVID-19, needs to be treated with caution.血管紧张素转换酶2（ACE2）作为新型冠状病毒肺炎（COVID-19）的一个治疗靶点，需要谨慎对待。
Arch Virol. 2025 May 29;170(7):143. doi: 10.1007/s00705-025-06327-0.
3
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.螺内酯与 DPP-4 抑制剂联合治疗 SARS-CoV-2 感染：文献综述。
Arch Virol. 2024 May 16;169(6):122. doi: 10.1007/s00705-024-06043-1.
Zotero 插件